Cargando…
CS-09 PROPOSAL OF A NEW CLASSIFICATION FOR DETERMINING THERAPEUTIC STRATEGY ACCORDING TO THE PROGRESSION OF OLFACTORY NEUROBLASTOMA
INTRODUCTION: Olfactory neuroblastoma (ONB) is a rare type of malignancy that infiltrates and propagates from the nasal cavity to the anterior skull base and into the cranium. Various treatment strategies have been used at different institutions and time of treatment. Although the staging system pro...
Autores principales: | Motegi, Hiroaki, Yamaguchi, Shigeru, Ishi, Yukitomo, Endo, Shogo, Kobayashi, Hiroyuki, Terasaka, Shunsuke, Suzuki, Masanobu, Nakamaru, Yuji, Homma, Akihiro, Houkin, Kiyohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213084/ http://dx.doi.org/10.1093/noajnl/vdz039.180 |
Ejemplares similares
-
ML-04 The influence of surgical intervention for high-dose Methotrexate chemotherapy in the patients with primary central nervous system lymphoma
por: Okamoto, Michinari, et al.
Publicado: (2020) -
Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis
por: YAMAGUCHI, Shigeru, et al.
Publicado: (2021) -
Successful Removal of a Metastatic Gastrointestinal Stromal Tumor in the Craniovertebral Junction using an Occipital Artery to Posterior Inferior Cerebellar Artery Bypass
por: Ishi, Yukitomo, et al.
Publicado: (2014) -
Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016) -
ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION
por: Yamaguchi, Shigeru, et al.
Publicado: (2019)